Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project,Alzheimer's & Dementia

当前位置： X-MOL 学术 › Alzheimers Dement. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
Alzheimer's & Dementia ( IF 14.0 ) Pub Date : 2021-07-26 , DOI: 10.1002/alz.12441
Mercè Boada _{1,

2} , Adrián Rodrigo ₃ , Frank Jessen _{4,

5} , Bengt Wimblad _{6,

7} , Milica G Kramberger ₈ , Pieter Jelle Visser _{9,

10} , Rafael Simó _{11,

12} , Octavio Rodríguez-Gomez ₁ , Andreea Ciudin _{11,

12} , Jean Georges ₁₃ , Annete Dumas ₁₄ , Peggy Maguire ₁₅ , David Krivec ₁₆ , Anders Wimo ₆ , Sergi Valero _{1,

2} , Montserrat Alegret _{1,

2} , Laura Jamilis ₃ , Marissa Zwan ₉ , Lena Sannemann ₄ , Jordi Arrufat ₁₇ , Erik Stomrud _{18,

19} , Gunilla Johansson ₆ , Craig Shering ₂₀ , Bridget Glaysher ₂₁ , Neil Stewart ₂₁ , Mark Belger ₂₂ , Fatima Iradier ₂₃ , Laura Campo ₂₄ ,

Affiliation

Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain.
GMV SECURE E SOLUTIONS, Valencia, Spain.
Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
Theme Aging, Karolinska Univ Hospital, Stockholm, Sweden.
Department of Neurology, University Medical Center Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain.
Alzheimer Europe, Luxembourg.
ASDM Consulting, Brussels, Belgium.
European Institute of Women's Health, Dublin, Ireland.
Zdruzenje Spomincica, Ljubljana, Slovenia.
EAP Sarrià-Vallvidrera-Les Planes, Barcelona, Spain.
Clinical Memory Research Unit, Lund University, Malmö, Sweden.
Emmaboda Health Centre, Region Kalmar County, Emmaboda, Sweden.
AstraZeneca, Waltham, Massachusetts, USA.
Modus Research and Innovation Limited, Dundee, Scotland.
Eli Lilly and Company (Lilly UK), Surrey, UK.
Eli Lilly and Company, Spain.
Eli Lilly and Company, Firenze, Italy.

The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis.

中文翻译：